Liora Katz

Has grant

Associate Professor

Icahn School of Medicine at Mount Sinai
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

The Role of Nrf2 in the Expansion and Preservation of Beta Cell Mass

Open Date: 2024-04-01

Close Date: 2029-03-01

Grant: Close

Alleviation of Glucotoxicity in Pancreatic Beta Cells

Open Date: 2021-07-01

Close Date: 2025-06-01

Grant: Close

Einstein - Mount Sinai Diabetes Research Center

Open Date: 2021-07-01

Close Date: 2025-06-01

Grant: Close

Myc Physiology in the Pancreatic Beta Cell

Open Date: 2020-07-01

Close Date: 2024-04-01

Grant: Close

ChREBP Isoforms in Pancreatic Beta Cells.

Open Date: 2017-01-01

Close Date: 2021-12-01

Articles (6)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

The Carbohydrate Response Element Binding Protein (ChREBP) is a glucose-responsive transcription factor (TF) with two major splice isoforms (α and β). In chronic hyperglycemia and glucolipotoxicity, ChREBPα-mediated ChREBPβ expression surges, leading to insulin-secreting β-cell dedifferentiation and death. 14-3-3 binding to ChREBPα results in cytoplasmic retention and suppression of transcriptional activity. Thus, small molecule-mediated stabilization of this protein-protein interaction (PPI) may be of therapeutic value. Here, we show that structure-based optimizations of a ‘molecular glue’ compound led to potent ChREBPα/14-3-3 PPI stabilizers with cellular activity. In primary human β-cells, the most active compound retained ChREBPα in the cytoplasm, and efficiently protected β-cells from glucolipotoxicity while maintaining β-cell identity. This study may thus not only provide the basis for the development of a unique class of compounds for the treatment of Type 2 Diabetes but also showcases an alternative ‘molecular glue’ approach for achieving small molecule control of notoriously difficult to target TFs. Graphical Abstract

Year:

2024

Year:

2023

Collaborators (8)

Donald Scott

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Luc Brunsveld

Prof. at Eindhoven University of Technology

Eindhoven University of Technology

NETHERLANDS
View details

Christian Ottmann

Eindhoven University of Technology

NETHERLANDS
View details

Peter Cossar

Research, Principal Investigator (Tenure Track)

Eindhoven University of Technology

NETHERLANDS
View details

Luca Lambertini

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Adolfo Garcia-Ocana

Professor and Chair

Beckman Research Institute

UNITED STATES
View details

Andrew Stewart

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Markus Kaiser

Universität Duisburg-Essen

GERMANY
View details